Literature DB >> 277

[Analysis of clinical phenomena and changes in physico-chemical properties of the blood in mentally ill children].

R Bichoński.   

Abstract

Entities:  

Mesh：

Year:  1975        PMID： 277

Source DB:  PubMed          Journal:  Folia Med Cracov        ISSN： 0015-5616


× No keyword cloud information.
  39 in total

1.  Thrombus aspiration during primary percutaneous coronary intervention.

Authors:  Tone Svilaas; Pieter J Vlaar; Iwan C van der Horst; Gilles F H Diercks; Bart J G L de Smet; Ad F M van den Heuvel; Rutger L Anthonio; Gillian A Jessurun; Eng-Shiong Tan; Albert J H Suurmeijer; Felix Zijlstra
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

2.  Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Authors:  Shamir R Mehta; Jean-Francois Tanguay; John W Eikelboom; Sanjit S Jolly; Campbell D Joyner; Christopher B Granger; David P Faxon; Hans-Jurgen Rupprecht; Andrzej Budaj; Alvaro Avezum; Petr Widimsky; Philippe Gabriel Steg; Jean-Pierre Bassand; Gilles Montalescot; Carlos Macaya; Giuseppe Di Pasquale; Kari Niemela; Andrew E Ajani; Harvey D White; Susan Chrolavicius; Peggy Gao; Keith A A Fox; Salim Yusuf
Journal:  Lancet       Date:  2010-10-09       Impact factor: 79.321

3.  Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.

Authors:  Robert J Goldberg; Frederick A Spencer; Joel M Gore; Darleen Lessard; Jorge Yarzebski
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

4.  Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

Authors:  Marc S Sabatine; Christopher P Cannon; C Michael Gibson; Jose L López-Sendón; Gilles Montalescot; Pierre Theroux; Marc J Claeys; Frank Cools; Karen A Hill; Allan M Skene; Carolyn H McCabe; Eugene Braunwald
Journal:  N Engl J Med       Date:  2005-03-09       Impact factor: 91.245

5.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

6.  Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

Authors:  D W Muller; E J Topol; S G Ellis; K N Sigmon; K Lee; R M Califf
Journal:  Am Heart J       Date:  1991-04       Impact factor: 4.749

7.  Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.

Authors:  Giuseppe De Luca; Harry Suryapranata; Jan Paul Ottervanger; Elliott M Antman
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

8.  Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.

Authors:  Pieter J Vlaar; Tone Svilaas; Iwan C van der Horst; Gilles F H Diercks; Marieke L Fokkema; Bart J G L de Smet; Ad F M van den Heuvel; Rutger L Anthonio; Gillian A Jessurun; Eng-Shiong Tan; Albert J H Suurmeijer; Felix Zijlstra
Journal:  Lancet       Date:  2008-06-07       Impact factor: 79.321

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.

Authors:  Gilles Montalescot; Stephen D Wiviott; Eugene Braunwald; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Elliott M Antman
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.